The Study of The ND5 Gene (G4540)

Target Name: ND5

NCBI ID: G4540

Content of Review Report on ND5 Target / Biomarker

ND5

The Study of The ND5 Gene

Native Developmental 5 (ND5) is a gene that has been identified in numerous studies as being involved in the development and progression of various diseases, including cancer. Its functions and implications as a potential drug target or biomarker make it an attractive target for researchers to explore.

The gene ND5 is located on chromosome 6p21.2 and has been shown to encode a non-coding RNA molecule that is involved in the regulation of gene expression. Studies have shown that the ND5 gene is highly expressed in various tissues and organs, including brain, heart, liver, and muscle. It is also expressed in various disease states, including cancer, suggesting that it may be a potential biomarker for disease.

One of the key functions of ND5 is its role in cell proliferation. Studies have shown that the ND5 gene is involved in the regulation of cell cycle progression, specifically in the G1/S transition. This is important because the G1/S transition is a critical step in the cell cycle that is associated with cell growth, differentiation, and survival. By regulating the cell cycle, ND5 may be involved in the development and maintenance of various diseases, including cancer.

Another function of ND5 is its role in cell survival. Studies have shown that the ND5 gene is involved in the regulation of apoptosis, which is a process that is responsible for cell death. This is important because apoptosis is a natural response of cells to various stimuli, including stress and damage. However, if apoptosis is not properly regulated, it can lead to the development of diseases such as cancer.

In addition to its functions in cell proliferation and survival, ND5 has also been shown to play a role in the development of diseases. Studies have shown that individuals with certain genetic variations, including those found in the ND5 gene, are at an increased risk of developing diseases such as cancer. This suggests that ND5 may be a potential drug target or biomarker for these diseases.

TheND5 gene has also been shown to be involved in the regulation of stem cell proliferation and differentiation. This is important because stem cells are a potential source of therapy for a variety of diseases, including cancer. TheND5 gene may be involved in the regulation of stem cell proliferation and differentiation, which could have implications for the development of stem cell-based therapies.

Overall, the ND5 gene is an attractive target for research as it is involved in the regulation of various functions that are important in the development and progression of diseases. As a potential drug target or biomarker, its study may provide new insights into the development and treatment of various diseases.

Protein Name: Mitochondrially Encoded NADH Dehydrogenase 5

Functions: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:15250827). Essential for the catalytic activity and assembly of complex I (PubMed:15250827)

The "ND5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ND5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets